The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|2|205-225

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.2, 2005-01, pp. : 205-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psychiatric Drug Discovery and Development

By Maubach Karen  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1571-1575

Informa Healthcare

Access to resources Recommend Favorite

Drug Development in Japan: Opportunities and Challenges in Drug Development

By Takahashi Kihito  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 17, Iss. 5, 2011-01 ,pp. : 410-423

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Anticonvulsant Drug Research: Strategies for Anticonvulsant Drug Development and Applications of Antiepileptic Drugs for Non-Epileptic Central Nervous System Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-05 ,pp. : 1033-1071

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV Drug Distribution to the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1313-1324

Bentham Science Publishers

Access to resources Recommend Favorite